234 related articles for article (PubMed ID: 29491441)
1. Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population.
Aoki T; Yamamoto Y; Ikenoue T; Onishi Y; Fukuhara S
Sci Rep; 2018 Feb; 8(1):3806. PubMed ID: 29491441
[TBL] [Abstract][Full Text] [Related]
2. Physical multimorbidity patterns and depressive symptoms: a nationwide cross-sectional study in Japan.
Aoki T; Yamamoto Y; Shimizu S; Fukuhara S
Fam Med Community Health; 2020; 8(1):e000234. PubMed ID: 32148733
[TBL] [Abstract][Full Text] [Related]
3. Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis.
Menditto E; Gimeno Miguel A; Moreno Juste A; Poblador Plou B; Aza Pascual-Salcedo M; Orlando V; González Rubio F; Prados Torres A
PLoS One; 2019; 14(2):e0210701. PubMed ID: 30726245
[TBL] [Abstract][Full Text] [Related]
4. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.
Hanlon P; Nicholl BI; Jani BD; McQueenie R; Lee D; Gallacher KI; Mair FS
BMJ Open; 2018 Jan; 8(1):e018404. PubMed ID: 29332840
[TBL] [Abstract][Full Text] [Related]
5. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
[TBL] [Abstract][Full Text] [Related]
6. A pharmacoepidemiologic study of community-dwelling, disabled older women: Factors associated with medication use.
Crentsil V; Ricks MO; Xue QL; Fried LP
Am J Geriatr Pharmacother; 2010 Jun; 8(3):215-24. PubMed ID: 20624611
[TBL] [Abstract][Full Text] [Related]
7. Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.
Nguyen TN; Ngangue P; Haggerty J; Bouhali T; Fortin M
Fam Pract; 2019 Nov; 36(6):706-712. PubMed ID: 31104072
[TBL] [Abstract][Full Text] [Related]
8. Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice.
von Buedingen F; Hammer MS; Meid AD; Müller WE; Gerlach FM; Muth C
BMC Fam Pract; 2018 Jul; 19(1):131. PubMed ID: 30055583
[TBL] [Abstract][Full Text] [Related]
9. Combined Multimorbidity and Polypharmacy Patterns in the Elderly: A Cross-Sectional Study in Primary Health Care.
Stafford G; Villén N; Roso-Llorach A; Troncoso-Mariño A; Monteagudo M; Violán C
Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501805
[TBL] [Abstract][Full Text] [Related]
10. Effect of multimorbidity patterns on the decline in health-related quality of life: a nationwide prospective cohort study in Japan.
Aoki T; Fukuhara S; Fujinuma Y; Yamamoto Y
BMJ Open; 2021 Jun; 11(6):e047812. PubMed ID: 34127493
[TBL] [Abstract][Full Text] [Related]
11. Patterns of multimorbidity and pharmacotherapy: a total population cross-sectional study.
Forslund T; Carlsson AC; Ljunggren G; Ärnlöv J; Wachtler C
Fam Pract; 2021 Mar; 38(2):132-140. PubMed ID: 32766818
[TBL] [Abstract][Full Text] [Related]
12. Changes in Multimorbidity and Polypharmacy Patterns in Young and Adult Population over a 4-Year Period: A 2011-2015 Comparison Using Real-World Data.
Mucherino S; Gimeno-Miguel A; Carmona-Pirez J; Gonzalez-Rubio F; Ioakeim-Skoufa I; Moreno-Juste A; Orlando V; Aza-Pascual-Salcedo M; Poblador-Plou B; Menditto E; Prados-Torres A
Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33919351
[TBL] [Abstract][Full Text] [Related]
13. Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study.
Zhao Y; Wang J; Zhu X; Zhang X; Zhang Y; Zhang W; Dong Y
BMC Geriatr; 2023 Jul; 23(1):423. PubMed ID: 37434147
[TBL] [Abstract][Full Text] [Related]
14. Multimorbidity patterns and the relation to self-rated health among older Japanese people: a nationwide cross-sectional study.
Honda Y; Nakamura M; Aoki T; Ojima T
BMJ Open; 2022 Sep; 12(9):e063729. PubMed ID: 36538382
[TBL] [Abstract][Full Text] [Related]
15. Late-life depression and the association with multimorbidity and polypharmacy: a cross-sectional study.
Holvast F; van Hattem BA; Sinnige J; Schellevis F; Taxis K; Burger H; Verhaak PFM
Fam Pract; 2017 Sep; 34(5):539-545. PubMed ID: 28369380
[TBL] [Abstract][Full Text] [Related]
16. Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication.
Loeppenthin K; Dalton SO; Johansen C; Andersen E; Christensen MB; Pappot H; Petersen LN; Thisted LB; Frølich A; Mortensen CE; Lassen U; Ørsted J; Bidstrup PE
Br J Cancer; 2020 Sep; 123(6):1033-1040. PubMed ID: 32632149
[TBL] [Abstract][Full Text] [Related]
17. Associations of primary care structures with polypharmacy and patient-reported indicators in patients with complex multimorbidity: a multicentre cross-sectional study in Japan.
Aoki T; Fujinuma Y; Matsushima M
BMJ Open; 2022 Jan; 12(1):e054348. PubMed ID: 34996796
[TBL] [Abstract][Full Text] [Related]
18. Polypharmacy patterns: unravelling systematic associations between prescribed medications.
Calderón-Larrañaga A; Gimeno-Feliu LA; González-Rubio F; Poblador-Plou B; Lairla-San José M; Abad-Díez JM; Poncel-Falcó A; Prados-Torres A
PLoS One; 2013; 8(12):e84967. PubMed ID: 24376858
[TBL] [Abstract][Full Text] [Related]
19. Number of medications or number of diseases: what influences underprescribing?
Gorup EC; Šter MP
Eur J Clin Pharmacol; 2017 Dec; 73(12):1673-1679. PubMed ID: 28920183
[TBL] [Abstract][Full Text] [Related]
20. Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study.
Villén N; Guisado-Clavero M; Fernández-Bertolín S; Troncoso-Mariño A; Foguet-Boreu Q; Amado E; Pons-Vigués M; Roso-Llorach A; Violán C
BMC Geriatr; 2020 Jun; 20(1):206. PubMed ID: 32532213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
